MEDSYS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDSYS
Largest movements
- Cash +€67,425
up €67,425 (+78.3%), from €86,132 to €153,557
mainly Other debts (+€123,491) and Net result for the year (+€87,987)
- Receivables within one year +€7,261
up €7,261 (+5.4%), from €133,303 to €140,564
of which Other amounts receivable: +€7,500
- Other debts +€123,491
new in 2025: €123,491
- Reserves -€80,290
down €80,290 (-66.9%), from €119,952 to €39,662
of which Distributable reserves: -€80,290
- Profit (loss) carried forward +€44,787
no longer reported in 2025 (was -€44,787)
- Trade debts -€20,985
down €20,985 (-46.6%), from €44,987 to €24,002
- Tax, wage and social debts +€6,446
up €6,446 (+64.0%), from €10,068 to €16,514
of which Taxes: +€5,613
- Staff costs -€60,208
down €60,208 (-42.4%), from €142,052 to €81,843
- Gross operating margin -€12,792
down €12,792 (-7.0%), from €183,064 to €170,272
- Financial income -€3,009
down €3,009 (-74.3%), from €4,049 to €1,039
of which Non-recurring financial income: -€3,959
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €330,221 | €403,669 | +€73,448 | +22.2% |
| Current assets | 29/58 | €330,221 | €403,669 | +€73,448 | +22.2% |
| Stocks and contracts in progress | 3 | €110,786 | €109,547 | -€1,238 | -1.1% |
| Stocks | 30/36 | €110,786 | €109,547 | -€1,238 | -1.1% |
| Amounts receivable within one year | 40/41 | €133,303 | €140,564 | +€7,261 | +5.4% |
| Trade receivables | 40 | €133,303 | €133,064 | -€239 | -0.2% |
| Other amounts receivable | 41 | - | €7,500 | +€7,500 | |
| Cash at bank and in hand | 54/58 | €86,132 | €153,557 | +€67,425 | +78.3% |
| Total equity and liabilities | 10/49 | €330,221 | €403,669 | +€73,448 | +22.2% |
| Equity | 10/15 | €275,166 | €239,662 | -€35,504 | -12.9% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Capital | 10 | €100,000 | €100,000 | = | 0.0% |
| Issued capital | 100 | €100,000 | €100,000 | = | 0.0% |
| Contributions outside capital | 11 | €100,000 | €100,000 | = | 0.0% |
| Share premium | 1100/10 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €119,952 | €39,662 | -€80,290 | -66.9% |
| Non-distributable reserves | 130/1 | €19,675 | €19,675 | = | 0.0% |
| Legal reserve | 130 | €19,675 | €19,675 | = | 0.0% |
| Distributable reserves | 133 | €100,277 | €19,987 | -€80,290 | -80.1% |
| Profit (loss) carried forward | 14 | -€44,787 | - | +€44,787 | |
| Amounts payable | 17/49 | €55,055 | €164,007 | +€108,952 | +198% |
| Amounts payable within one year | 42/48 | €55,055 | €164,007 | +€108,952 | +198% |
| Trade debts | 44 | €44,987 | €24,002 | -€20,985 | -46.6% |
| Suppliers | 440/4 | €44,987 | €24,002 | -€20,985 | -46.6% |
| Taxes, remuneration and social security | 45 | €10,068 | €16,514 | +€6,446 | +64.0% |
| Taxes | 450/3 | - | €5,613 | +€5,613 | |
| Remuneration and social security | 454/9 | €10,068 | €10,901 | +€833 | +8.3% |
| Other amounts payable | 47/48 | - | €123,491 | +€123,491 | |
| Remuneration, social security and pensions | 62 | €142,052 | €81,843 | -€60,208 | -42.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €379 | - | -€379 | |
| Other operating charges | 640/8 | €45 | €565 | +€520 | +1,155% |
| Gross operating margin | 9900 | €183,064 | €170,272 | -€12,792 | -7.0% |
| Operating profit (loss) | 9901 | €40,588 | €87,864 | +€47,275 | +116% |
| Financial income | 75/76B | €4,049 | €1,039 | -€3,009 | -74.3% |
| Recurring financial income | 75 | €90 | €1,039 | +€950 | +1,060% |
| Non-recurring financial income | 76B | €3,959 | - | -€3,959 | |
| Financial charges | 65/66B | €1,861 | €644 | -€1,217 | -65.4% |
| Recurring financial charges | 65 | €1,797 | €644 | -€1,153 | -64.2% |
| Non-recurring financial charges | 66B | €64 | - | -€64 | |
| Profit (loss) for the period before taxes | 9903 | €42,776 | €88,259 | +€45,483 | +106% |
| Income taxes | 67/77 | €241 | €272 | +€30 | +12.6% |
| Profit (loss) for the period | 9904 | €42,535 | €87,987 | +€45,453 | +107% |
| Profit (loss) for the period to be appropriated | 9905 | €42,535 | €87,987 | +€45,453 | +107% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.